Benchmark Botanics Stock Performance
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Benchmark Botanics are completely uncorrelated.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Benchmark Botanics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's forward-looking signals remain nearly stable which may send shares a bit higher in May 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
| Begin Period Cash Flow | 250.4 K | |
| Total Cashflows From Investing Activities | -216.7 K |
Benchmark |
Benchmark Botanics Relative Risk vs. Return Landscape
If you would invest 0.34 in Benchmark Botanics on January 2, 2025 and sell it today you would lose (0.34) from holding Benchmark Botanics or give up 100.0% of portfolio value over 90 days. Benchmark Botanics is currently producing negative expected returns and takes up 12.9099% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than Benchmark, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Benchmark Botanics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Benchmark Botanics' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Benchmark Botanics, and traders can use it to determine the average amount a Benchmark Botanics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1291
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | BHHKF |
Estimated Market Risk
| 12.91 actual daily | 96 96% of assets are less volatile |
Expected Return
| -1.67 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.13 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Benchmark Botanics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Benchmark Botanics by adding Benchmark Botanics to a well-diversified portfolio.
Benchmark Botanics Fundamentals Growth
Benchmark Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Benchmark Botanics, and Benchmark Botanics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Benchmark Pink Sheet performance.
| Return On Equity | -11.56 | |||
| Return On Asset | -0.21 | |||
| Operating Margin | (18.13) % | |||
| Current Valuation | 6.45 M | |||
| Shares Outstanding | 58.99 M | |||
| Price To Book | 0.88 X | |||
| Price To Sales | 4.61 X | |||
| Revenue | 1.01 M | |||
| EBITDA | (12.61 M) | |||
| Cash And Equivalents | 273.03 K | |||
| Total Debt | 8.08 M | |||
| Debt To Equity | 1.50 % | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (2.73 M) | |||
| Earnings Per Share | (0.39) X | |||
| Total Asset | 6.52 M | |||
About Benchmark Botanics Performance
By analyzing Benchmark Botanics' fundamental ratios, stakeholders can gain valuable insights into Benchmark Botanics' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Benchmark Botanics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Benchmark Botanics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Craftport Cannabis Corp. engages in the production and sale of recreational cannabis under the Craftport Cannabis brand in Canada. Craftport Cannabis Corp. is headquartered in Peachland, Canada. Craftport Cannabis is traded on OTC Exchange in the United States.Things to note about Benchmark Botanics performance evaluation
Checking the ongoing alerts about Benchmark Botanics for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Benchmark Botanics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Benchmark Botanics generated a negative expected return over the last 90 days | |
| Benchmark Botanics has high historical volatility and very poor performance | |
| Benchmark Botanics has some characteristics of a very speculative penny stock | |
| Benchmark Botanics has a very high chance of going through financial distress in the upcoming years | |
| Benchmark Botanics has accumulated 8.08 M in total debt with debt to equity ratio (D/E) of 1.5, which is about average as compared to similar companies. Benchmark Botanics has a current ratio of 0.13, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Benchmark Botanics until it has trouble settling it off, either with new capital or with free cash flow. So, Benchmark Botanics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Benchmark Botanics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Benchmark to invest in growth at high rates of return. When we think about Benchmark Botanics' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 1.01 M. Net Loss for the year was (10.06 M) with loss before overhead, payroll, taxes, and interest of (62.33 K). | |
| Benchmark Botanics has accumulated about 273.03 K in cash with (2.73 M) of positive cash flow from operations. |
- Analyzing Benchmark Botanics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Benchmark Botanics' stock is overvalued or undervalued compared to its peers.
- Examining Benchmark Botanics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Benchmark Botanics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Benchmark Botanics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Benchmark Botanics' pink sheet. These opinions can provide insight into Benchmark Botanics' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Benchmark Pink Sheet analysis
When running Benchmark Botanics' price analysis, check to measure Benchmark Botanics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Benchmark Botanics is operating at the current time. Most of Benchmark Botanics' value examination focuses on studying past and present price action to predict the probability of Benchmark Botanics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Benchmark Botanics' price. Additionally, you may evaluate how the addition of Benchmark Botanics to your portfolios can decrease your overall portfolio volatility.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |